Evidence map›Paper›PMID 28685198›Full record

ReviewDer Urologe. Ausg. A2017

[Geriatric urology : Increasingly important in urological care].

A Wiedemann

Abstract readHistorical ArticleReview
PubMed Publisher
In one paragraph

Review in Der Urologe. Ausg. A, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

A WiedemannUrologische Klinik, Lehrstuhl für Geriatrie, Universität Witten/Herdecke, Ev. Krankenhaus Witten gGmbh, Pferdebachstr. 27, 58455, Witten, Deutschland. awiedemann@evk-witten.de.
Witten/Herdecke University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urology will benefit by demographic change more than other disciplines in the next 10 years. Both number of patients and their intensity of treatment will increase. This implies the need of a reorientation of urology away from oncologic topics towards geriatric urology. Relevant issues are functional disorders of the lower urinary tract, infectiology, hematuria, and benign prostate hyperplasia. The legislature of North Rhine-Westphalia has already made the first step towards geriatric urology by the foundation of the ISAR screening for each geriatric patient outside geriatrics, which constitutes the possibility of beginning an early interdisciplinary dialogue. Considering the geriatric patient as being defined by age, multimorbidity, multimedication, and the resulting vulnerability, there are new fields of work in urology. These lie in research areas such as cognitive alterations after urologic surgery or medications and the adjustment of urologic methods to the specific requirements of these patients.

Indexed as

Population DynamicsAgedComorbidityFemaleForecastingGeriatricsGermanyHistory, 18th CenturyHumansInterdisciplinary CommunicationIntersectoral CollaborationMaleMass ScreeningRisk FactorsUrologyAnticholinergic agentsCognitionProstate syndrome, benignUrinary tract, lowerUrogeriatrics

Identifiers

PMID28685198
OpenAlexW2729337017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.